Braveheart Bio, Inc. (BRVE) earnings
Quarterly results of Braveheart Bio, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 4 quarters, the latest results release and when the next one is expected.
Latest quarter: Q2 FY2026
In Q2 FY2026 (ended June 30, 2026) Braveheart Bio, Inc. reported revenue of - and a net loss of $15M.
Diluted earnings per share were -$2.51.
Quarter by quarter
| Quarter | Revenue | vs year ago | Net income | EPS |
|---|---|---|---|---|
| Q2 FY2026 | - | - | -$15M | -$2.51 |
| Q2 FY2026 | - | - | -$14.3M | - |
| Q2 FY2026 | - | - | -$381K | -$0.14 |
| Q2 FY2026 | - | - | -$99K | - |
Results filings
- Quarterly report 10-Q
- Quarterly results 8-K
Get an email when BRVE reports
Follow BRVE and we email you its next results the day they are filed, with the numbers explained.